<DOC>
	<DOCNO>NCT01697423</DOCNO>
	<brief_summary>The incidence cartilage pathology grow due age population , increase sport participation associate trauma . The aim treatment symptomatic osteoarthritis consist reduce pain improve knee function order limit sport , professional social negative impact young patient . The symptomatic treatment knee osteoarthritis associate painkiller non steroid anti inflammatory drug ( nsad ) . In case ineffectiveness oral drug intra articular injection propose . Intra articular injection hyaluronic acid recommend American College Rheumatology European League Rheumatism treatment knee osteoarthritis . Nevertheless efficacy remain non predictable patient duration clinical improvement exceed 6 month . The articular cartilage limited capacity self-repair due low mitotic activity chondrocytes avascularity . Platelet-rich plasma natural concentrate growth factor : PDGF , TGF b , IGF-1 , FGF cytokine , liberate platelet degranulation . The influence growth factor cartilage repair widely investigate vivo vitro . These factor could stimulate chondral reparation via neovascularization , collagen synthesis activation chondrocytes . The hypothesis intra articular injection PRP , capacity enhance articular cartilage repair , could therapeutic alternative hyaluronic acid treatment knee osteoarthritis resist oral drug . Material method : We intend conduct comparative , monocentric prospective randomize , double-blind study 80 patient symptomatic knee osteoarthritis compare result 2 intra articular treatment : platelet-rich plasma hyaluronic acid .</brief_summary>
	<brief_title>Comparative Assessment Intra-articular Knee Injections Platelet-rich Plasma ( PRP ) Hyaluronic Acid Treatment Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Males females 20 75 year age 2 . Symptomatic knee arthritis 3 . Axial deformity lower limb equal low 5° 4 . BMI 20 30 5 . Written informed consent , sign patient legal representative ( patient unable sign ) . 6 . HB &gt; 10g/dl 7 . Negative pregnancy test 1 . Axial deformity lower limb 5° 2 . Knee instability 3 . BMI &lt; 20 &gt; 30 4 . Thrombocytopenia &lt; 150 G/L 5 . Thrombopathy 6 . Anaemia : HB &lt; 10g/dl 7 . Positive serology VIH1 2 , Agp24 , Ac HCV , Ag HbS , AcHbc , Ac HTLV I II , TPHA 8 . Chronic treatment corticosteroid per o treatment complete 2 week inclusion 9 . Intra articular knee injection corticosteroid complete 8 week inclusion 10 . Intra articular knee injection hyaluronic complete 24 week inclusion 11 . NSAI treatment complete 2 week inclusion 12 . Fever recent disease 13 . Auto immune disease 14 . Inflammatory Arthritis 15 . Immune deficit 16 . Infectious disease 17 . Pregnancy 18 . Patient guardianship . 19 . Participation another investigational trial within trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>